"O Hospital CUF Descobertas, em Lisboa, disponibiliza um conjunto de serviços clínicos, como Atendimento Permanente de Adultos, Pediátrico e de Ginecologia-Obstetrícia."

During the past decade, Hospital CUF Descobertas conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 3 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 1 clinical trials were completed. i.e. 8.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital CUF Descobertas" #1 sponsor was "Janssen Research & Development, LLC" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Academia Cuf Descobertas" with 1 trials sponsored, "Actelion" with 1 trials sponsored and "Alector Inc." with 1 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital CUF Descobertas" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Brugmann University Hospital" with 1 trials as a collaborator, "CUF Academic and Research Medical Center" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator and "Helsinn Healthcare SA" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Hospital CUF Descobertas" are "Follicular Lymphoma" (2 trials), "Advanced Cholangiocarcinoma" (1 trials), "Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials), "All Tumor Types" (1 trials) and "Attention Deficit Hyperactivity Disorder" (1 trials). Many other conditions were trialed in "Hospital CUF Descobertas" in a lesser frequency.

Most popular intervention types in "Hospital CUF Descobertas" are "Drug" (13 trials), "Biological" (3 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Cisplatin" (2 trials), "Placebo" (2 trials), "1L PEG + ASCORBIC ACID" (1 trials) and "5-FU" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital CUF Descobertas" are 18 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital CUF Descobertas". undefined are not yet recruiting, 8 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hospital CUF Descobertas, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital CUF Descobertas, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".